Novo Nordisk’s new top executive will need to help the company close the gap with Eli Lilly, fend off emerging rivals and ...

Eli Lilly plans to pursue approval for its new GLP-1 pill by the end of this year. Fact checked by Nick Blackmer A daily pill ...

Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial funded by Eli Lilly.

Many people using GLP-1 weight-loss drugs like Ozempic, Wegovy or Mounjaro regain the weight after stopping-experts explain ...

Researchers at the Tony Blair Institute have called for the eligibility criteria for the drugs to 'drastically lowered', ...

Dozens of Ozempic and Wegovy users have reported suffering from eye disorders they claim are associated with the drugs, ...

Novo Nordisk is parting ways with its CEO Lars Fruergaard Jørgensen after the two parties mutually agreed that a change of ...

IT feels like everyone is talking about – or taking – weight loss medications like Wegovy or Mounjaro. The jabs have ...

Weight loss drugs have become an increasingly popular, but controversial, way of quickly shedding extra pounds over the past ...

Compounding pharmacies are supposed to stop producing the compounded versions of the popular weight loss medications now that ...

I never imagined that coming off a medication could feel like stepping off a cliff. But here I am, bracing for the freefall.

As weight loss medications like Ozempic continue to gain popular, experts and patients are noticing varying effects of the drugs for people with eating disorders.